Ann: EMD-RX5 program advancing Phase 1 clinical trials underway, page-7

  1. 1,309 Posts.
    lightbulb Created with Sketch. 327
    660ml revenue annually for their current product and looking to expand further into eruope.

    so will approach 1billion revenue globally soon.

    So whats the opportunity to lower their cost base on that revenue by 50%= substantial bottom line improvements.

    Very compelling story unfolding here.

    ive only got 60,000 shares but think this could be a very good investment in the next 12-18 months
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.4¢
Change
0.003(9.68%)
Mkt cap ! $20.78M
Open High Low Value Volume
3.0¢ 3.4¢ 3.0¢ $209.6K 6.565M

Buyers (Bids)

No. Vol. Price($)
1 136872 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 546220 3
View Market Depth
Last trade - 16.10pm 17/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.